Amendment: SEC Form SCHEDULE 13D/A filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 7)
|
Anheuser-Busch InBev SA/NV (Name of Issuer) |
Ordinary Shares, without nominal value (Title of Class of Securities) |
03524A108 (CUSIP Number) |
W. Hildebrandt Surgner, Jr. 6601 West Broad Street, Richmond, VA, 23230 (804) 274-2200 Andrew J. Nussbaum 51 West 52nd Street, New York, NY, 10019 (212) 403-1000 Zachary S. Podolsky 51 West 52nd Street, New York, NY, 10019 (212) 403-1000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
02/07/2025 (Date of Event Which Requires Filing of This Statement) |
![Checkbox not checked](https://www.sec.gov/Images/box-unchecked.jpg)
SCHEDULE 13D
|
CUSIP No. | 03524A108 |
1 |
Name of reporting person
Altria Group, Inc. | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
![]() ![]() | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
WC, OO | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
6 | Citizenship or place of organization
VIRGINIA
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
1,020,598,157.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
13 | Percent of class represented by amount in Row (11)
51.9 % | ||||||||
14 | Type of Reporting Person (See Instructions)
CO |
SCHEDULE 13D
|
Item 1. | Security and Issuer | |
(a) | Title of Class of Securities:
Ordinary Shares, without nominal value | |
(b) | Name of Issuer:
Anheuser-Busch InBev SA/NV | |
(c) | Address of Issuer's Principal Executive Offices:
Brouwerijplein 1, 3000 Leuven,
BELGIUM
, 0. | |
Item 1 Comment:
This Amendment No. 7 is being filed by Altria Group, Inc. ("Altria") in order to amend and supplement certain of the information set forth in the Schedule 13D (as so amended, the "Schedule 13D") originally filed by Altria on October 21, 2016, and amended by Amendment No. 1 thereto filed on June 16, 2021, by Amendment No. 2 thereto filed on November 3, 2021, by Amendment No. 3 thereto filed on March 14, 2024, by Amendment No. 4 thereon filed on March 20, 2024, by Amendment No. 5 thereon filed on June 21, 2024 and by Amendment No. 6 thereon filed on October 1, 2024, with respect to the ordinary shares without nominal value ("Ordinary Shares") of Anheuser-Busch InBev SA/NV, a public limited liability company incorporated in the form of a societe anonyme/naamloze vennootschap under Belgian law (the "Issuer"). Each Item below amends and supplements the information disclosed under the corresponding Item of the Schedule 13D. Except as specifically provided herein, this Amendment No. 7 does not modify any of the information previously reported in the Schedule 13D. Unless otherwise indicated herein, capitalized terms used but not defined in this Amendment No. 7 shall have the same meanings herein as are ascribed to such terms in the Schedule 13D. | ||
Item 2. | Identity and Background | |
(b) | Item 2 of the Schedule 13D is hereby amended by amending and restating Schedule A, which is attached hereto as Exhibit 1 and incorporated herein by reference. | |
Item 5. | Interest in Securities of the Issuer | |
(c) | The information set forth within Item 5 of the Schedule 13D is hereby supplemented as follows: Prior to joining Altria's Board of Directors on February 3, 2025, Richard S. Stoddart sold three Ordinary Shares beneficially owned by him on December 26, 2024. | |
Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer | |
The information set forth under the caption "Terms of Restricted Shares-Governance Rights" within Item 6 of the Scehdule 13D is hereby amended and restated as follows:
So long as the holders of Restricted Shares (together with their affiliates, successors and successors' affiliates) own or control within the meaning of Article 5 of the Belgian Companies Code:
- more than 13.5% of the issued and outstanding Voting Shares, three directors shall be appointed by the shareholders' meeting of the Issuer upon proposal by the holders of the Restricted Shares;
- more than 9% but not more than 13.5% of the issued and outstanding Voting Shares, two directors shall be appointed by the shareholders' meeting of the Issuer upon proposal by the holders of the Restricted Shares; and
- more than 4.5% but not more than 9% of the issued and outstanding Voting Shares, one director shall be appointed by the shareholders' meeting of the Issuer upon proposal by the holders of the Restricted Shares.
In accordance with the Articles of Association, the percentage of Voting Shares necessary for the appointment of directors is determined 120 days before the Issuer's annual shareholders' meeting. For purposes of the calculations set forth above, the denominator is determined in accordance with the Articles of Association, which excludes certain shares which have been disposed of by the Issuer from the treasury shares the Issuer held at the completion of the combination with SABMiller.
As of December 31, 2024, the holders of Restricted Shares, including their respective ownership of Ordinary Shares, owned approximately 13.64% of the issued and outstanding Voting Shares included in the calculations set forth above. The foregoing percentage, using the denominator determined per the above, is based on a total of 1,921,164,955 Voting Shares. Based on these calculation provisions and the provisions on the appointment of directors in the Articles of Association, and as a result of the Voting Agreement (as described below), Altria's percentage ownership of Voting Shares of the Issuer provides it with the effective ability to select two directors for appointment to the Issuer's Board of Directors. | ||
Item 7. | Material to be Filed as Exhibits. | |
1 - Directors and Executive Officers |
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|